Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Annual Report and Accounts for the year ended 30 June 2012

Financial History

2012
£'000
2011
£'000
2010
£'000
2009
£'000
2008
£'000
Consolidated income statement
Revenue426,041389,237369,369349,964304,371
Underlying operating profit36,60131,82328,19024,97119,142
Underlying profit before taxation32,96630,06926,05623,40616,853
Underlying profit after taxation24,30222,74819,43716,75912,185
Underlying earnings per share    — basic (pence)32.37*31.53*27.09*23.52*19.11*
— diluted (pence)32.37*31.43*26.99*23.33*18.96*
Dividend per share (pence)12.27*11.12*9.64*8.36*7.58*
Average number of employees1,0421,0051,0211,012889
Consolidated statement of financial position
Non-current assets242,592132,81988,04497,60599,652
Working capital49,53132,49421,48617,54817,284
Deferred and contingent consideration(13,863)(14,055)
Current tax liabilities(8,155)(5,391)(4,105)(4,756)(2,824)
Deferred tax liabilities(29,343)(13,443)(12,496)(14,184)(15,316)
Employee benefit obligations(363)
Net borrowings(86,717)(34,091)(6,701)(15,527)(26,997)
Shareholders' funds153,68298,33386,22880,68671,799
Consolidated cash flow
Cash flow from operating activities29,12825,37426,66227,55716,053
Net interest paid(2,426)(2,629)(2,208)(1,851)(2,802)
Tax paid(7,241)(5,034)(6,124)(3,227)(3,041)
Net capital expenditure(3,228)(4,090)(2,721)(3,634)(2,112)
Acquisitions(117,335)(33,047)(65,151)
Equity dividends paid(8,325)(7,221)(6,195)(5,565)(4,420)
Financing112,03326,090(4,626)(8,843)66,500
Changes in cash in period2,606(557)4,7884,4375,027

* Restated to reflect the impact of the bonus element of the Rights Issue.

We use cookies and track users anonymously, check this box and save to disable. We are inferring consent by continuing.